XENCOR INC
XNCRNASDAQ🏆 #2046 by market capEarnings Nov 3US Equity
$25.00▼ $0.59 (−2.34%)
🌙 After hours$25.00▲ 0.00%Regular close · extended-hours price shownTrack XNCR
Get earnings, price moves & breaking news on Telegram
24h▼ 2.3%
7d▲ 3.2%
14d▲ 5.6%
30d▼ 8.3%
ytd▲ 63.4%
1y▲ 113.3%
🏦Market Cap
$1.85B
Small Cap
📈Revenue Growth (YoY)
+13.7%
Healthy
📊Gross Margin
43.3%
Healthy
💵FCF Margin
-198.4%
Thin
⚖️P/S Ratio
17.7x
Expensive
Otter Score
72
Fair
XENCOR INC
XNCRAnalyst Ratings
Price
$25.00
Total
28
Raised
2
Lowered
1
Avg PT
$34.40
H / L
$46 / $20
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Truist Securities | Reiterated | Buy | 2026-09-28 | — | — |
B of A Securities | Reiterated | Neutral | 2026-09-21 | — | — |
Barclays | Reiterated | Overweight | 2026-09-11 | $35.00 | +40.00% |
JP Morgan | Reiterated | Neutral | 2026-09-03 | — | — |
Raymond James | Reiterated | Strong Buy | 2026-09-01 | $46.00 | +84.00% |
Wedbush | Reiterated | Outperform | 2026-08-06 | $26.00 | +4.00% |
RBC Capital | Reiterated | Outperform | 2026-08-06 | $20.00 | −20.00% |
Cantor Fitzgerald | Reiterated | Overweight | 2026-08-06 | $44.00 | +76.00% |
Wells Fargo | Reiterated | Overweight | 2025-08-07 | — | — |
Piper Sandler | Upgraded | Neutral → Overweight | 2024-12-02 | $30.00 | +20.00% |
BMO Capital | Reiterated | Outperform | 2024-11-08 | $32.00 | +28.00% |
BTIG | Reiterated | Buy | 2024-04-16 | $38.00 | +52.00% |
Mizuho | Reiterated | Buy | 2024-01-22 | — | — |
Guggenheim | Reiterated | Buy | 2023-11-08 | $54.00 | +116.00% |
Canaccord Genuity | Reiterated | Buy | 2023-02-24 | — | — |
EF Hutton | Reiterated | Buy | 2023-02-24 | — | — |
Cowen & Co. | Reiterated | Outperform | 2022-12-06 | — | — |
HC Wainwright & Co. | Reiterated | Buy | 2022-02-24 | — | — |
SVB Leerink | Reiterated | Outperform | 2021-08-05 | — | — |
Guggenheim Securities | Upgraded | Neutral → Buy | 2020-02-25 | — | — |
Berenberg | Reiterated | Buy | 2019-03-27 | — | — |
Nomura | Downgraded | Neutral → Reduce | 2019-02-22 | — | — |
BTIG Research | Reiterated | Buy | 2018-06-07 | — | — |
PiperJaffray | Reiterated | Overweight | 2016-10-04 | — | — |
Leerink Swann | Reiterated | Outperform | 2016-03-10 | — | — |
Credit Suisse | Reiterated | Outperform | 2015-05-06 | — | — |
Oppenheimer | Reiterated | Outperform | 2015-02-12 | — | — |
MLV & Co. | Reiterated | Buy | 2014-10-23 | — | — |
Institution
Truist Securities
Reiterated · Buy · 2026-09-28
—
—
B of A Securities
Reiterated · Neutral · 2026-09-21
—
—
Barclays
Reiterated · Overweight · 2026-09-11
$35.00
+40.00%
JP Morgan
Reiterated · Neutral · 2026-09-03
—
—
Raymond James
Reiterated · Strong Buy · 2026-09-01
$46.00
+84.00%
Wedbush
Reiterated · Outperform · 2026-08-06
$26.00
+4.00%
RBC Capital
Reiterated · Outperform · 2026-08-06
$20.00
−20.00%
Cantor Fitzgerald
Reiterated · Overweight · 2026-08-06
$44.00
+76.00%
Wells Fargo
Reiterated · Overweight · 2025-08-07
—
—
Piper Sandler
Upgraded · Neutral → Overweight · 2024-12-02
$30.00
+20.00%
BMO Capital
Reiterated · Outperform · 2024-11-08
$32.00
+28.00%
BTIG
Reiterated · Buy · 2024-04-16
$38.00
+52.00%
Mizuho
Reiterated · Buy · 2024-01-22
—
—
Guggenheim
Reiterated · Buy · 2023-11-08
$54.00
+116.00%
Canaccord Genuity
Reiterated · Buy · 2023-02-24
—
—
EF Hutton
Reiterated · Buy · 2023-02-24
—
—
Cowen & Co.
Reiterated · Outperform · 2022-12-06
—
—
HC Wainwright & Co.
Reiterated · Buy · 2022-02-24
—
—
SVB Leerink
Reiterated · Outperform · 2021-08-05
—
—
Guggenheim Securities
Upgraded · Neutral → Buy · 2020-02-25
—
—
Berenberg
Reiterated · Buy · 2019-03-27
—
—
Nomura
Downgraded · Neutral → Reduce · 2019-02-22
—
—
BTIG Research
Reiterated · Buy · 2018-06-07
—
—
PiperJaffray
Reiterated · Overweight · 2016-10-04
—
—
Leerink Swann
Reiterated · Outperform · 2016-03-10
—
—
Credit Suisse
Reiterated · Outperform · 2015-05-06
—
—
Oppenheimer
Reiterated · Outperform · 2015-02-12
—
—
MLV & Co.
Reiterated · Buy · 2014-10-23
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space